A Huntington’s gene therapy by UniQure has made waves after slowing disease progression by 75% in a mid-stage trial. During ...

New data from a gene therapy trial provide the first credible evidence that the progression of Huntington’s disease may be ...

In a study reported by Uniqure, which developed the experimental gene therapy, scientists found that it slowed progression of ...

The neurodegenerative disease damages patients' motor, cognitive and behavioral controls, which sometimes manifest as ...

AMT-130 is the first gene therapy tested in people with Huntington’s disease. It was developed by uniQure, a company based in ...